Search - tctmd.com

Displaying 281 - 300 of 546

Sort: Relevancy | Date

News Daily News

Transfemoral TAVR Carries Similar Vascular Complication Risk With or Without Surgical Cutdown

Todd Neale

July 24, 2014

News Daily News

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Yael L. Maxwell

July 24, 2014

News Daily News

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

Yael L. Maxwell

July 24, 2014

News Daily News

La TAVR Transfemoral acarrea un Riesgo Similar de Complicaciones Vasculares Con o Sin Disección Quirúrgica

Todd Neale

July 24, 2014

News Daily News

La Anestesia Local se ‘Prefiere’ a la General en la realización de TAVR Transfemorales

Yael L. Maxwell

July 24, 2014

News Daily News

患者特征可预测TAVR后的永久起搏器需求

Yael L. Maxwell

July 10, 2014

News Daily News

VIVID登记处：瓣中瓣TAVR的益处取决于手术后退化生物瓣膜的大小、状态

July 10, 2014

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

News Daily News

Registro VIVID: El Beneficio de la TAVR Válvula dentro de Otra Válvula Depende del Tamaño y del Estatus de Bioprótesis Quirúrgica Fallida

July 10, 2014

News Daily News

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Yael L. Maxwell

July 10, 2014

News Daily News

Los Rasgos del Paciente Predicen la Necesidad de Implantación de un Marcapasos Permanente Post-TAVR

Yael L. Maxwell

July 10, 2014

News Daily News

Sapien XT Given Go-Ahead to Make US Debut

Caitlin E. Cox

June 24, 2014

News Daily News

Sapien XT Aprobado; Hará su Aparición en EE.UU.

Caitlin E. Cox

June 24, 2014

News Daily News

La Válvula CoreValve Aprobada para TAVR en Pacientes de Alto Riesgo

June 17, 2014

News Daily News

CoreValve Approved for TAVR in High-Risk Patients

June 17, 2014

News Daily News

Treatment Delays May Undermine TAVR Efficacy

June 11, 2014

News Daily News

Los Retrasos en el Tratamiento Podrían Minar la Eficacia de la TAVR

June 11, 2014

Presentation TVT 2014

SAPIEN 3 Sizing Considerations: The Concept of True Sizing and Balloon-Volume Reduction

Presenter: John G. Webb

June 07, 2014

Presentation TVT 2014

TAVI in A Bicuspid Aortic Valve Stenosis With Edwards Sapien 3 In A Thrilling Scenario

Presenter: Caterina Gandolfo

June 06, 2014

Presentation TVT 2014

Aortic Dissection after Sapien 3

Presenter: Augusto D. Pichard

June 06, 2014

Advertisement

Transfemoral TAVR Carries Similar Vascular Complication Risk With or Without Surgical Cutdown

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

La TAVR Transfemoral acarrea un Riesgo Similar de Complicaciones Vasculares Con o Sin Disección Quirúrgica

La Anestesia Local se ‘Prefiere’ a la General en la realización de TAVR Transfemorales

患者特征可预测TAVR后的永久起搏器需求

VIVID登记处：瓣中瓣TAVR的益处取决于手术后退化生物瓣膜的大小、状态

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

Registro VIVID: El Beneficio de la TAVR Válvula dentro de Otra Válvula Depende del Tamaño y del Estatus de Bioprótesis Quirúrgica Fallida

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Los Rasgos del Paciente Predicen la Necesidad de Implantación de un Marcapasos Permanente Post-TAVR

Sapien XT Given Go-Ahead to Make US Debut

Sapien XT Aprobado; Hará su Aparición en EE.UU.

La Válvula CoreValve Aprobada para TAVR en Pacientes de Alto Riesgo

CoreValve Approved for TAVR in High-Risk Patients

Treatment Delays May Undermine TAVR Efficacy

Los Retrasos en el Tratamiento Podrían Minar la Eficacia de la TAVR

SAPIEN 3 Sizing Considerations: The Concept of True Sizing and Balloon-Volume Reduction

TAVI in A Bicuspid Aortic Valve Stenosis With Edwards Sapien 3 In A Thrilling Scenario

Aortic Dissection after Sapien 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content